Cargando…

Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia

BACKGROUND: Despite the availability of numerous antipsychotic medications, many patients with schizophrenia continue to experience side effects that contribute to the overall burden of the illness. The present survey of patients with schizophrenia and schizoaffective disorder aimed to assess patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Achtyes, Eric, Simmons, Adam, Skabeev, Anna, Levy, Nikki, Jiang, Ying, Marcy, Patricia, Weiden, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142379/
https://www.ncbi.nlm.nih.gov/pubmed/30223804
http://dx.doi.org/10.1186/s12888-018-1856-y
_version_ 1783355847554891776
author Achtyes, Eric
Simmons, Adam
Skabeev, Anna
Levy, Nikki
Jiang, Ying
Marcy, Patricia
Weiden, Peter J.
author_facet Achtyes, Eric
Simmons, Adam
Skabeev, Anna
Levy, Nikki
Jiang, Ying
Marcy, Patricia
Weiden, Peter J.
author_sort Achtyes, Eric
collection PubMed
description BACKGROUND: Despite the availability of numerous antipsychotic medications, many patients with schizophrenia continue to experience side effects that contribute to the overall burden of the illness. The present survey of patients with schizophrenia and schizoaffective disorder aimed to assess patient attitudes toward antipsychotic treatment, and understand key factors about willingness to try a new medication. METHODS: A cross-sectional survey was administered to 250 patients with a primary clinical diagnosis of a schizophrenia spectrum disorder across five outpatient clinics in the United States. The survey included self-reported gender, age, weight, and height, and questions about the importance of efficacy and side effects on the decision to take a prescribed antipsychotic medication. RESULTS: Patients rated efficacy and side effects as important attributes of antipsychotic treatment, with 93.6% and 83.6% of patients listing these as “very” or the “most” important factors in taking prescribed medication. A total of 87.6% of respondents identified the ability to think more clearly as an important property of their medication. Patients identified weight gain, physical restlessness, and somnolence as important side effects of current treatments (“very” or “most” important by 61.6%, 60.8%, and 58.8%, respectively). When asked about willingness to change antipsychotic medication, anticipated weight gain had a negative influence on willingness to try the new treatment, with 22.0% declining to try a medication that would lead to weight gain of 2.7–4.5 kg (6–10 lb), 34.0% declining for anticipated weight gain of 5.0–9.1 kg (11–20 lb), and 52.4% declining for anticipated weight gain greater than 9 kg (20 lbs). CONCLUSION: Patients living with schizophrenia spectrum disorders are influenced by many factors when considering whether to take their medication, including efficacy and side effects. It is important for clinicians to assess specific patient concerns to develop a comprehensive treatment plan that maximizes adherence to the prescribed therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12888-018-1856-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6142379
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61423792018-09-20 Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia Achtyes, Eric Simmons, Adam Skabeev, Anna Levy, Nikki Jiang, Ying Marcy, Patricia Weiden, Peter J. BMC Psychiatry Research Article BACKGROUND: Despite the availability of numerous antipsychotic medications, many patients with schizophrenia continue to experience side effects that contribute to the overall burden of the illness. The present survey of patients with schizophrenia and schizoaffective disorder aimed to assess patient attitudes toward antipsychotic treatment, and understand key factors about willingness to try a new medication. METHODS: A cross-sectional survey was administered to 250 patients with a primary clinical diagnosis of a schizophrenia spectrum disorder across five outpatient clinics in the United States. The survey included self-reported gender, age, weight, and height, and questions about the importance of efficacy and side effects on the decision to take a prescribed antipsychotic medication. RESULTS: Patients rated efficacy and side effects as important attributes of antipsychotic treatment, with 93.6% and 83.6% of patients listing these as “very” or the “most” important factors in taking prescribed medication. A total of 87.6% of respondents identified the ability to think more clearly as an important property of their medication. Patients identified weight gain, physical restlessness, and somnolence as important side effects of current treatments (“very” or “most” important by 61.6%, 60.8%, and 58.8%, respectively). When asked about willingness to change antipsychotic medication, anticipated weight gain had a negative influence on willingness to try the new treatment, with 22.0% declining to try a medication that would lead to weight gain of 2.7–4.5 kg (6–10 lb), 34.0% declining for anticipated weight gain of 5.0–9.1 kg (11–20 lb), and 52.4% declining for anticipated weight gain greater than 9 kg (20 lbs). CONCLUSION: Patients living with schizophrenia spectrum disorders are influenced by many factors when considering whether to take their medication, including efficacy and side effects. It is important for clinicians to assess specific patient concerns to develop a comprehensive treatment plan that maximizes adherence to the prescribed therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12888-018-1856-y) contains supplementary material, which is available to authorized users. BioMed Central 2018-09-12 /pmc/articles/PMC6142379/ /pubmed/30223804 http://dx.doi.org/10.1186/s12888-018-1856-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Achtyes, Eric
Simmons, Adam
Skabeev, Anna
Levy, Nikki
Jiang, Ying
Marcy, Patricia
Weiden, Peter J.
Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia
title Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia
title_full Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia
title_fullStr Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia
title_full_unstemmed Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia
title_short Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia
title_sort patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142379/
https://www.ncbi.nlm.nih.gov/pubmed/30223804
http://dx.doi.org/10.1186/s12888-018-1856-y
work_keys_str_mv AT achtyeseric patientpreferencesconcerningtheefficacyandsideeffectprofileofschizophreniamedicationsasurveyofpatientslivingwithschizophrenia
AT simmonsadam patientpreferencesconcerningtheefficacyandsideeffectprofileofschizophreniamedicationsasurveyofpatientslivingwithschizophrenia
AT skabeevanna patientpreferencesconcerningtheefficacyandsideeffectprofileofschizophreniamedicationsasurveyofpatientslivingwithschizophrenia
AT levynikki patientpreferencesconcerningtheefficacyandsideeffectprofileofschizophreniamedicationsasurveyofpatientslivingwithschizophrenia
AT jiangying patientpreferencesconcerningtheefficacyandsideeffectprofileofschizophreniamedicationsasurveyofpatientslivingwithschizophrenia
AT marcypatricia patientpreferencesconcerningtheefficacyandsideeffectprofileofschizophreniamedicationsasurveyofpatientslivingwithschizophrenia
AT weidenpeterj patientpreferencesconcerningtheefficacyandsideeffectprofileofschizophreniamedicationsasurveyofpatientslivingwithschizophrenia